Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

974
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
974
What is Cancer?02:12

What is Cancer?

10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SERENA-6 and the regulatory limits of radiologic progression in modern oncology.

Breast cancer research and treatment·2026
Same author

Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies-A Narrative Review.

Diagnostics (Basel, Switzerland)·2026
Same author

Robotic subtotal pancreatectomy for multifocal neuroendocrine tumour of the pancreas.

BMJ case reports·2026
Same author

Immunotherapy and surgical decision-making in Lynch syndrome-associated colorectal cancer: Implications for personalized management and guideline revision.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Benefits and harms of antiresorptive therapy in men with non-metastatic prostate cancer on androgen deprivation therapy: A systematic review and meta-analysis of randomized controlled trials.

Metabolism: clinical and experimental·2026
Same author

Cancer patients' insights and experience of palliative and supportive care in the UAE: a qualitative study.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jun 16, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Cancer control in the United Arab Emirates.

Deborah Mukherji1, Ibtihal Fadhil2, Walid Faraj3

  • 1Clemenceau Medical Center Hospital, Dubai, United Arab Emirates; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

The Lancet. Oncology
|June 14, 2025
PubMed
Summary
This summary is machine-generated.

The United Arab Emirates faces a growing cancer burden. A comprehensive national cancer control plan is crucial, focusing on early detection, advanced treatments, and workforce development to improve patient outcomes.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 16, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K

Area of Science:

  • Oncology
  • Public Health
  • Health Policy

Background:

  • The United Arab Emirates (UAE) experiences a significant and increasing cancer burden.
  • This rising incidence strains healthcare resources, workforce productivity, and the national economy.
  • The UAE's unique demographics and healthcare system necessitate a specialized cancer control strategy.

Purpose of the Study:

  • To evaluate the current state of cancer control in the UAE.
  • To identify existing barriers and gaps within the national cancer control system.
  • To propose actionable recommendations for enhancing cancer care and outcomes.

Main Methods:

  • Review of the current cancer control landscape in the UAE.
  • Analysis of barriers and gaps in screening, diagnosis, and treatment.
  • Formulation of recommendations aligned with national health agendas.

Main Results:

  • A comprehensive national cancer control plan is urgently required.
  • Key areas for improvement include early detection, screening expansion, and access to multidisciplinary centers.
  • Enhancing the oncology workforce, adopting new technologies, and fostering partnerships are critical.

Conclusions:

  • Implementing a robust national cancer control plan is essential for the UAE.
  • Strategic initiatives focusing on early detection, advanced diagnostics, and workforce development will optimize patient outcomes.
  • The proposed measures aim to establish a regional benchmark for equitable, high-quality cancer care.